PRKDC and neoplasm: Of particular interest, E-cadherin and claudin 7 (typical epithelial markers) are positively correlated with the IC50 value (Figure 5C), indicating that DNA-PKcs inhibitors preferentially target mesenchymal cells that are actively involved in tumor metastasis and therapy resistance [34,80].